{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:38:18Z","timestamp":1783633098213,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.bone.2012.02.637","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T16:31:03Z","timestamp":1331224263000},"page":"1260-1265","source":"Crossref","is-referenced-by-count":13,"title":["5-HIAA excretion is not associated with bone metabolism in carcinoid syndrome patients"],"prefix":"10.1016","volume":"50","author":[{"given":"S.C.","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.W.","family":"de Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Kwekkeboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.N.","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.T.M.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2012.02.637_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bone.2012.02.637_bb0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1016\/j.bone.2012.02.637_bb0015","series-title":"Histological typing of endocrine tumours","author":"Solcia","year":"2000"},{"key":"10.1016\/j.bone.2012.02.637_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000225948","article-title":"Mallorca Consensus Conference participants, European Neuroendocrine Tumor Society, ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biochemical markers","volume":"90","author":"O'Toole","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.bone.2012.02.637_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00292-010-1385-z","article-title":"The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment","volume":"31","author":"Kloppel","year":"2010","journal-title":"Pathologe"},{"key":"10.1016\/j.bone.2012.02.637_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00428-010-0924-6","article-title":"The ENETS and AJCC\/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement","volume":"456","author":"Kloppel","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.bone.2012.02.637_bb0035","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND, WHO classification of tumours of the digestive system. 4th ed. WHO classification of Tumours, No 3. 2010."},{"key":"10.1016\/j.bone.2012.02.637_bb0040","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bone.2012.02.637_bb0045","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1572-0241.2004.40507.x","article-title":"Carcinoid tumors and fibrosis: an association with no explanation","volume":"99","author":"Modlin","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bone.2012.02.637_bb0050","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2009.51","article-title":"Fibrosis and carcinoid syndrome: from causation to future therapy","volume":"5","author":"Druce","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bone.2012.02.637_bb0055","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2012.02.637_bb0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00004728-199505000-00012","article-title":"Midgut carcinoid tumors: CT findings and biochemical profiles","volume":"19","author":"Woodard","year":"1995","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.bone.2012.02.637_bb0065","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMc030888","article-title":"Carcinoid heart disease","volume":"348","author":"Zuetenhorst","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2012.02.637_bb0070","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2012.02.637_bb0075","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/cncr.11226","article-title":"Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor","volume":"97","author":"Zuetenhorst","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2012.02.637_bb0080","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1111\/j.1572-0241.2004.40507.x","article-title":"Carcinoid tumors and fibrosis: an association with no explanation","volume":"99","author":"Modlin","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bone.2012.02.637_bb0085","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2012.02.637_bb0090","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/CIRCULATIONAHA.107.701367","article-title":"Carcinoid heart disease","volume":"116","author":"Bhattacharyya","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2012.02.637_bb0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2009.51","article-title":"Fibrosis and carcinoid syndrome: from causation to future therapy","volume":"5","author":"Druce","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bone.2012.02.637_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/qjmed\/hcp191","article-title":"Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine (\u2018carcinoid\u2019) tumours of the small bowel","volume":"103","author":"Druce","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.bone.2012.02.637_bb0105","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjcard.2010.12.025","article-title":"Risk factors for the development and progression of carcinoid heart disease","volume":"107","author":"Bhattacharyya","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bone.2012.02.637_bb0110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.bone.2006.06.009","article-title":"Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells","volume":"39","author":"Bliziotes","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.02.637_bb0115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S8756-3282(01)00593-2","article-title":"Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake","volume":"29","author":"Bliziotes","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.02.637_bb0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcb.20734","article-title":"Serotonin and fluoxetine modulate bone cell function in vitro","volume":"98","author":"Gustafsson","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2012.02.637_bb0125","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.cellsig.2005.06.006","article-title":"Stepwise control of osteogenic differentiation by 5-HT(2B) receptor signaling: nitric oxide production and phospholipase A2 activation","volume":"18","author":"Locker","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.bone.2012.02.637_bb0130","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1074\/jbc.M101824200","article-title":"Expression of serotonin receptors in bone","volume":"276","author":"Westbroek","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2012.02.637_bb0135","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jcb.21177","article-title":"Long-term fluoxetine administration does not result in major changes in bone architecture and strength in growing rats","volume":"101","author":"Westbroek","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2012.02.637_bb0140","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","article-title":"Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum","volume":"135","author":"Yadav","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bone.2012.02.637_bb0145","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1210\/en.2010-0499","article-title":"Minireview: a skeleton in serotonin's closet?","volume":"151","author":"Kawai","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2012.02.637_bb0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/en.2004-1259","article-title":"Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth","volume":"146","author":"Warden","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2012.02.637_bb0155","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JCP.0b013e31817e0ecb","article-title":"Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures","volume":"28","author":"Ziere","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bone.2012.02.637_bb0160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/clinchem\/40.1.86","article-title":"Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors","volume":"40","author":"Kema","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2012.02.637_bb0165","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0378-4347(00)83867-0","article-title":"Chromatography of urinary indole derivatives","volume":"429","author":"van Haard","year":"1988","journal-title":"J Chromatogr"},{"key":"10.1016\/j.bone.2012.02.637_bb0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1677\/joe.0.1770337","article-title":"A comparison between three commercial kits for chromogranin A measurements","volume":"177","author":"Stridsberg","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bone.2012.02.637_bb0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1349-7006.1993.tb02869.x","article-title":"Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone","volume":"84","author":"Chiba","year":"1993","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.bone.2012.02.637_bb0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2005.11.034","article-title":"The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization","volume":"248","author":"Eijken","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bone.2012.02.637_bb0185","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/clinchem\/46.10.1588","article-title":"Discriminating capacity of indole markers in the diagnosis of carcinoid tumors","volume":"46","author":"Meijer","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2012.02.637_bb0190","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2012.02.637_bb0195","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/pgmj.71.839.542","article-title":"The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid","volume":"71","author":"Tormey","year":"1995","journal-title":"Postgrad Med J"},{"issue":"Pt 2","key":"10.1016\/j.bone.2012.02.637_bb0200","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/000456328902600208","article-title":"Simultaneous assay for urinary 4-hydroxy-3-methoxy-mandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid by isocratic HPLC with electrochemical detection","volume":"26","author":"Davidson","year":"1989","journal-title":"Ann Clin Biochem"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212007168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212007168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T23:01:48Z","timestamp":1593817308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328212007168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S8756328212007168"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2012.02.637","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}